Batson, J., Toop, H. D., Redondo, C., Babaei-Jadidi, R., Chaikaud, A., Wearmouth, S. F., . . . Morris, J. C. (2017). Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease. American Chemical Society.
Chicago Style (17th ed.) CitationBatson, Jennifer, et al. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. American Chemical Society, 2017.
MLA (9th ed.) CitationBatson, Jennifer, et al. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. American Chemical Society, 2017.
Warning: These citations may not always be 100% accurate.